BIO (6-bromoindirubin-3'-oxime) GSK3 inhibitor induces dopaminergic differentiation of human immortalized RenVm cells

Comparative Clinical Pathology
Mitra SoleimaniFatemeh Mohammadi Chamnari

Abstract

Parkinson's disease (PD) is one of the most neurodegenerative disorders which can lead to severe neural disability and neurological defects. Cell-based therapy using fully differentiated cells is a new method for the treatment of this abnormal condition. In the present study, we investigated the effects of 6-bromoindirubin-3'-oxime (BIO) on dopaminergic differentiation of human immortalized RenVm cells in order to obtain a set of fully differentiated cells for transplantation in Parkinson's disease. To this end, the immortalized RenVm cells were induced to dopaminergic differentiation using a neuro basal medium supplemented with N2 and different concentrations (75, 150, 300, 600, and 1200 nM) of BIO for 4, 8, and 12 days. The efficiency of dopaminergic differentiation was determined using immunocytochemistry for tyrosine hydroxylase expressions. In addition, the expression of a β-catenin marker was measured using the western blot technique. The results of immunocytochemistry revealed that the mean percentage of Tuj1- and TH-positive sells in 150- and 300-nM-BIO-treated groups was significantly increased compared to that of other groups (p ≤ 0.01). In addition, the expression of the β-catenin marker was higher in these groups as...Continue Reading

References

Jun 14, 2000·Current Opinion in Neurobiology·A Patapoutian, L F Reichardt
Oct 12, 2000·Nature·K I PinsonW C Skarnes
Mar 30, 2001·The Journal of Biological Chemistry·S FukumotoM E Lee
Jun 27, 2001·The Journal of Biological Chemistry·M KishidaA Kikuchi
Sep 18, 2002·The Journal of Biological Chemistry·Wolfgang HolnthonerPeter Petzelbauer
Feb 24, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Jen-Chih Hsieh
Mar 6, 2004·Science·W James Nelson, Roel Nusse
Apr 27, 2004·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Tatsuo MichiueMakoto Asashima
May 4, 2004·Molecular and Cellular Neurosciences·Markus PanhuysenWolfgang Wurst
Dec 25, 2004·Developmental Biology·Victor V Chizhikov, Kathleen J Millen
Nov 7, 2007·Neurology·Angelika D WahnerBeate Ritz
Dec 18, 2007·Molecular and Cellular Neurosciences·Kadiombo BantubungiSerge N Schiffmann
Jul 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mathew Blurton-JonesFrank M LaFerla

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.